8
Oct
2024

Hangzhou Jiuyuan Gene Engineering Co.,Lt

Exhibitor at CPHI Milan 2024 stand 4D105, API
About Us

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Liraglutide(recombinant)，Enoxaparin sodium, Fulvestrant, Interleukin-eleven (oprelvekin), Palonosetron Hydrochloride, rhBMP-2 (recombinant human Bone Morphogenetic Protein-2). Our product pipeline include: Semaglutide(recombinant), Semaglutide intermediate (Totally 29 amino acids)， Recombinant Hyaluronidasec，Fosaprepitant dimeglumine, Peg-Filgrastim, Dulaglutide, Ranibizumab, Rivaroxaban, Avatrombopag maleate, Daratumumab. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4D105, API

Products Featured at CPHI Milan 2024

  • Enoxaparin sodium

    Product Enoxaparin sodium

    anticoagulant and antithrombotic, Low Molecular Weight Heparin, Clexane, Lovenox, l  Active pharmaceutical ingredient (API), l  Injection (PFS/ampoule/vial), 0.2ml:2000AxaIU(20mg), 0.4ml:4000AxaIU(40mg), 0.6ml:6000AxaIU(60mg), 0.8ml:8000AxaIU(80mg), 10ml:100,000AxaIU(1g), or other...
  • Filgrastim

    Product Filgrastim

    Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l  Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit

  • Fosaprepitant dimeglumine

    Product Fosaprepitant dimeglumine

    cancerbrhrbrEmend, CAS number: 265121-04-8
  • Dulaglutide

    Product Dulaglutide

    diabetes (recombinant route), API
  • Fulvestrant

    Product Fulvestrant

    an anti-cancer drug， Bulk and injection (PFS): 250mg in 5ml